|

F-DCFPyL Injection Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Imaging agent

Pipeline

Phase 2/3: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Recurrent Prostate Cancer1
  • Prostate Cancer1
  • Cancer1

Tampa, Florida1 trial

PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

H. Lee Moffitt Cancer Center and Research Institute

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.